We are live on ! Find out more
KOD icon

Kodiak Sciences

107 hedge funds and large institutions have $419M invested in Kodiak Sciences in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

307% more capital invested

Capital invested by funds: $103M → $419M (+$316M)

101% more call options, than puts

Call options by funds: $543K | Put options by funds: $270K

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

10% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 29

9% more funds holding

Funds holding: 98107 (+9)

5.07% more ownership

Funds ownership: 74.92%79.99% (+5.1%)

Holders
107
Holders Change
+9
Holders Change %
+9.18%
% of All Funds
1.41%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
32
Reduced
29
Closed
14
Calls
$543K
Puts
$270K
Net Calls
+$273K
Net Calls Change
+$285K
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.68M +$44.1K +7,678 +3%
NCM
27
Nantahala Capital Management
Connecticut
$2.65M +$1.14M +197,756 +287%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$2.19M +$112K +19,561 +10%
UBS Group
29
UBS Group
Switzerland
$1.67M +$873K +151,830 +965%
PLC
30
Peapod Lane Capital
New York
$1.66M +$959K +166,843 New
TD Asset Management
31
TD Asset Management
Ontario, Canada
$1.66M +$957K +166,400 New
BFM
32
Boothbay Fund Management
New York
$1.57M +$163K +28,420 +22%
N
33
Nuveen
North Carolina
$1.39M -$33.1K -5,761 -4%
BCM
34
Bridgeway Capital Management
Texas
$1.39M
JP Morgan Chase
35
JP Morgan Chase
New York
$1.31M +$500K +86,998 +195%
RAG
36
RIA Advisory Group
Iowa
$1.18M +$260K +45,289 +62%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$976K +$28.3K +4,927 +5%
PAM
38
Panagora Asset Management
Massachusetts
$941K +$37.4K +6,511 +7%
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$902K +$521K +90,691 New
Los Angeles Capital Management
40
Los Angeles Capital Management
California
$876K -$99.5K -17,300 -16%
Millennium Management
41
Millennium Management
New York
$816K +$282K +49,019 +149%
GCP
42
GSA Capital Partners
United Kingdom
$777K -$1.21M -209,671 -73%
SEI Investments
43
SEI Investments
Pennsylvania
$739K -$400K -69,599 -48%
Barclays
44
Barclays
United Kingdom
$736K -$32.9K -5,731 -7%
AllianceBernstein
45
AllianceBernstein
Tennessee
$711K
Deutsche Bank
46
Deutsche Bank
Germany
$672K +$54.2K +9,433 +16%
American Century Companies
47
American Century Companies
Missouri
$597K +$20.2K +3,515 +6%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$512K +$7.08K +1,232 +2%
Two Sigma Investments
49
Two Sigma Investments
New York
$492K +$57.1K +9,941 +25%
AI
50
Atom Investors
Texas
$476K +$275K +47,880 New

KOD Hedge Fund Activity: Q4 2024 in Review

107 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Kodiak Sciences (KOD) for Q4 2024, worth a combined $419M — up 307% from $103M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new KOD positions and 14 closed out — a net gain of 9 holders — while 32 added to existing stakes and 29 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $7.23M. The largest seller was Acadian Asset Management, cutting an estimated $2.43M.

  • 107 institutional investors held Kodiak Sciences (KOD) as of Q4 2024, up from 98 in Q3 2024.
  • Funds reported $419M of Kodiak Sciences stock for Q4 2024, up 307% quarter-over-quarter.
  • 23 funds opened new Kodiak Sciences positions in Q4 2024 and 14 closed out, a net change of +9 holders.
  • The largest Kodiak Sciences buyer in Q4 2024 was T. Rowe Price Associates, an estimated $7.23M added.
  • The largest Kodiak Sciences seller in Q4 2024 was Acadian Asset Management, an estimated $2.43M sold.

Based on aggregated 13F filings for Q4 2024.